ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
ASLN was delisted on the 18th of July, 2024.
21 hedge funds and large institutions have $24.6M invested in ASLAN Pharmaceuticals Limited American Depositary Shares in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 0 closing their positions.
144% more capital invested
Capital invested by funds: $10.1M → $24.6M (+$14.5M)
31% more funds holding
Funds holding: 16 → 21 (+5)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$4.06M |
| 2 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$1.96M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
+$210K |
| 4 |
WW
Waterfront Wealth
Overland Park,
Kansas
|
+$13.8K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$7.49K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$1.43M |
| 2 |
Millennium Management
New York
|
-$190K |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
-$144K |
| 4 |
Renaissance Technologies
New York
|
-$47.3K |
| 5 |
Morgan Stanley
New York
|
-$4.64K |
ASLN Hedge Fund Activity: Q2 2023 in Review
21 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) for Q2 2023, worth a combined $24.6M — up 144% from $10.1M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ASLN positions and 0 closed out — a net gain of 5 holders — while 2 added to existing stakes and 6 trimmed.
The largest buyer was BVF Inc, opening a new position worth an estimated $4.06M. The largest seller was Citadel Advisors, cutting an estimated $1.43M.
- 21 institutional investors held ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) as of Q2 2023, up from 16 in Q1 2023.
- Funds reported $24.6M of ASLAN Pharmaceuticals Limited American Depositary Shares stock for Q2 2023, up 144% quarter-over-quarter.
- 5 funds opened new ASLAN Pharmaceuticals Limited American Depositary Shares positions in Q2 2023 and 0 closed out, a net change of +5 holders.
- The largest ASLAN Pharmaceuticals Limited American Depositary Shares buyer in Q2 2023 was BVF Inc, an estimated $4.06M added.
- The largest ASLAN Pharmaceuticals Limited American Depositary Shares seller in Q2 2023 was Citadel Advisors, an estimated $1.43M sold.
Based on aggregated 13F filings for Q2 2023.